Clinical Trials Browser

Interventional × regorafenib × 30 days × Clear all

NCT07495579 2026-05-27

REVIVE

Phase 2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT05064059 2026-05-26

MK-4280A-007

Phase 3 Completed

441 enrolled 24 charts

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

NCT04503694 2026-05-22

REGINA

Phase 2 Active not recruiting

Gastrointestinal

Rectal Neoplasms

NCT04787341 2026-05-20

PARERE

Phase 2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT06246643 2026-05-19

A Study of Continued Treatment With Regorafenib in Participants With Solid Tumors Who Have Participated in Other Bayer Studies

Phase 2 Active not recruiting

Solid Malignant Tumors

NCT02693535 2026-05-15

TAPUR

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms

NCT03970447 2026-05-15

GBM AGILE

Phase 2/3 Recruiting

Glioblastoma, Recurrence

NCT06275919 2026-05-13

MIRAGE

Phase 2 Recruiting

Meningioma

NCT07567222 2026-05-06

Clinical Study of Novel Therapeutic Vaccine for Advanced Solid Tumors

Phase 1 Recruiting

Neoplasms